In a lawsuit lodged over non-production of antibodies following the first dose of Covishield, the Lucknow District and Sessions Court has summoned Adar Poonawala, CEO of Serum Institute of India and seven individuals on April 1.
A gentleman from Lucknow submitted the case claiming that despite having taken a Covishield dosage, he did not acquire antibodies, reports India Today.
The police station in Lucknow where the complaint was registered was Aashiana. DCGA director, Joint Secretary of Health Ministry Luv Agarwal, ICMR director Balaram Bhargava, and National Health Mission director Aparna Upadhyay are among those listed in the allegation.
Pratap Chandra, the plaintiff, stated in his complaint that he got his first dose of Covishield on April 8. Chandra stated he was meant to have his second dose 28 days later, but on that day, he was informed it had been delayed by six weeks. The period between the two dosages was then adjusted to 12 weeks by the government.
After the first injection, Chandra stated that he was not feeling good. The claimant acquired a Covid Antibody GT test from a government-approved laboratory, quoting ICMR director general Balram Bhargav’s statements in the media that “good levels of antibodies are produced in the body after the first dose of Covishield.”
Subscribe to GreatGameIndia
The test found that the plaintiff had developed no antibodies to Covid-19, but his platelets had been lowered from 3 lakh to 1.5 lakh.
Chandra claims that since receiving the vaccine, his platelet level has dropped by half, making him more susceptible to the virus.
Earlier, a major lawsuit was filed against Bill Gates, Adar Poonawalla and the Indian government alongside several health officials for the death of a 23 year old young adult following the AstraZeneca COVID vaccination.
Another case filed in the Bombay High Court by the father of a medical student has demanded a compensation of Rs 1,000 crore, stating that his daughter died as a result of the Covid-19 vaccine’s negative effects.
Covishield vaccine maker Serum Institute of India, its partner Bill Gates, as well as state and federal authorities, are named as respondents in the petition.